Sequana Medical N.V stock analysis
Sequana Medical N.V (2SE) Stock Price & Analysis
2SE Stock Chart & Stats
- Day’s Range
- EUR 0.51 - EUR 0.51
- 52-Week Range
- EUR 0.37 - EUR 0.79
- Previous Close
- EUR 0.51
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- EUR 47.76M
- Enterprise Value
- EUR 114.92M
- Total Cash (Recent Filing)
- EUR 3.81M
- Total Debt (Recent Filing)
- EUR 40.11M
- Price to Earnings (P/E)
- ―
- Beta
- 0.48
- Next Earnings
- Mar 26, 2027 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Sequana Medical N.V News
2SE FAQ
What was Sequana Medical N.V’s price range in the past 12 months?
What is Sequana Medical N.V’s market cap?
When is Sequana Medical N.V’s upcoming earnings report date?
How were Sequana Medical N.V’s earnings last quarter?
Is Sequana Medical N.V overvalued?
Does Sequana Medical N.V pay dividends?
What is Sequana Medical N.V’s EPS estimate?
How many shares outstanding does Sequana Medical N.V have?
What happened to Sequana Medical N.V’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Sequana Medical N.V?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Sequana Medical N.V
Sequana Medical N.V. is a medical technology company that has reached the commercial stage, dedicated to creating innovative solutions for managing excessive fluid accumulation linked to liver conditions, malignant ascites, and heart failure. The company's key offerings include the alfapump® system, an implanted device specifically designed to treat severe and resistant liver ascites as well as malignant ascites (fluid buildup caused by cancer). Additionally, it provides Direct Sodium Removal (DSR) technology to address ongoing fluid congestion in patients with heart failure. This DSR technology is integrated into the alfapump® DSR system, a fully implantable solution for direct sodium removal therapy in heart failure patients experiencing fluid overload. Established in 2006 and headquartered in Ghent, Belgium, Sequana Medical operates across Belgium, Germany, France, Switzerland, and other international regions.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Ian Crosbie
- Employees
- 48
- Website
- www.sequanamedical.com
- Address
- Kortrijksesteenweg 1112, Gent, 9051, BE
Sequana Medical N.V (2SE) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 14 | 2 | 4 |
| Technical Analysis | 5 | 1 | 2 |
| Moving Averages | 9 | 1 | 2 |
Similar Stocks
| Company | Price & Change | Follow |
|---|---|---|
| DE:2S0SATS ASA |


